MAM-2201
MAM-2201[edit]
MAM-2201 is a synthetic cannabinoid that acts as a potent agonist of the cannabinoid receptors. It is a member of the indole family of synthetic cannabinoids and is structurally related to other compounds such as JWH-018 and AM-2201.
Chemical Properties[edit]
MAM-2201 is chemically known as 1-(5-fluoropentyl)-3-(4-methyl-1-naphthoyl)indole. It is a fluorinated derivative of AM-2201, with the addition of a methyl group on the naphthoyl ring. This modification enhances its binding affinity to the CB1 and CB2 receptors, making it a highly potent synthetic cannabinoid.
Pharmacology[edit]
MAM-2201 acts as a full agonist at the CB1 and CB2 receptors, which are part of the endocannabinoid system. These receptors are involved in a variety of physiological processes including pain sensation, mood, and memory. The activation of these receptors by MAM-2201 can lead to effects similar to those of tetrahydrocannabinol (THC), the active component of cannabis.
Effects and Usage[edit]
The effects of MAM-2201 are similar to those of other synthetic cannabinoids and can include euphoria, relaxation, altered perception, and increased appetite. However, due to its high potency, it can also cause adverse effects such as anxiety, paranoia, and tachycardia. MAM-2201 has been used recreationally, often sprayed onto herbal mixtures and sold as "spice" or "K2."
Legal Status[edit]
Due to its potential for abuse and lack of medical use, MAM-2201 has been classified as a controlled substance in many countries. It is often included in legislation targeting synthetic cannabinoids and "designer drugs."
